International Journal of Chronic Diseases / 2017 / Article / Tab 2

Research Article

Lipid Profile in Tuberculosis Patients with and without Human Immunodeficiency Virus Infection

Table 2

(a) Baseline lipid profile levels (mg/dl) among HIV negative study groups (month 0)

Lipid nameHIV−TB+
()
HIV−TST+
()
HIV−TST−
()
value
HIV−TB+ versus HIV−TST+
value
HIV−TB+ versus HIV−TST−
value
HIV−TST+ versus HIV−TST−
value

TC108 ( 87–130)149 (140.5–162)158 (150–192)<0.001<0.0010.119
TG75 (66–84)83.5 (73–110.5)119 (82–119)0.027<0.0010.180
LDL59.3 (46.9–73.2)73.35 (63.8–87.2)80.4 (73.5–105.1)0.001<0.0010.072
HDL26.5 (21.1–31.8)42.4 (37.05–49.3)44.7 (37.4–54.6)<0.001<0.0010.276

Median (interquartile range) micronutrient level values are shown at baseline and significant differences between study groups were determined using Kruskal-Wallis H and Wilcoxon Mann–Whitney test.
(b) The proportional of the abnormality of lipid profile level among study groups at baseline

Lipid nameHIV+TB+
()
HIV−TB+
()
HIV+TST+
()
HIV−TST+
()
HIV−TST−
()
value using Pearson Chi2

TC < 130 mg/dl, N (%)38 (86)36 (73)11 (65)2 (8)4 (4)<0.001
TC ≥ 200 mg/dl, N (%)0 (0)0 (0)0 (0)1 (4)6 (24)<0.001
TG < 90 mg/dl, N (%)30 (68)40 (82)13 (76)14 (58)8 (32)0.001
TG ≥ 150 mg/dl, N (%)0 (0)0 (0)0 (0)2 (8)2 (8)0.056
LDL < 100 mg/dl, N (%)43 (98)46 (94)15 (88)19 (79)17 (68)0.002
LDL ≥ 130 mg/dl, N (%)0 (0)1 (2)0 (0)1 (4)1 (4)0.652
HDL < 40 mg/dl, N (%)43 (98)43 (88)13 (76)10 (42)9 (36)<0.001
HDL > 40 mg/dl, N (%)1 (2)6 (12)4 (24)14 (58)16 (64)0.000
TC < 130 & TG < 90 & LDL < 100 & HDL < 4025 (40)28 (44)8 (13)2 (3)0 (0)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.